4//SEC Filing
Moreadith Randall 4
Accession 0001301120-25-000035
CIK 0001708599other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 7:56 PM ET
Size
8.6 KB
Accession
0001301120-25-000035
Insider Transaction Report
Form 4
Moreadith Randall
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-16$0.06/sh+3,227$194→ 3,227 total - Sale
Common Stock
2025-12-16$2.96/sh−3,227$9,562→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-16−3,227→ 361,959 totalExercise: $0.06Exp: 2031-05-06→ Common Stock (3,227 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $2.96. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F2]The stock options are fully vested.
Documents
Issuer
Serina Therapeutics, Inc.
CIK 0001708599
Entity typeother
Related Parties
1- filerCIK 0001301120
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 7:56 PM ET
- Size
- 8.6 KB